Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
AT20:FRA
Atara Biotherapeutics Inc
3,84 €
-3,03%
(-0,12) 1D
30 apr, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for AT20...
Açın
3,84 €
High
3,84 €
Low
3,84 €
Mkt. cap
41,71 mln
Avg. vol.
15,00
Volume
0,00
52-wk high
16,30 €
52-wk low
3,48 €
No. of employees
14
News stories
From sources across the web
About Atara Biotherapeutics Inc
CEO-
Employees14
Founded2012
HeadquartersTauzand Oks, Kaliforniya, Amerika Birləşmiş Ştatları
Sector-
Websiteatarabio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
98,15 mln
17,58 mln
3,45 mln
1,60 mln
Cost of goods sold
39,52 mln
554,00K
3,02 mln
783,00K
Cost of revenue
39,52 mln
554,00K
3,02 mln
783,00K
Research and development expenses
-
6,37 mln
-
2,86 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,01 mln
5,94 mln
3,98 mln
3,37 mln
Operating expense
10,01 mln
12,30 mln
3,98 mln
6,23 mln
Total operating expenses
49,53 mln
12,86 mln
7,00 mln
7,01 mln
Operating income
48,62 mln
4,72 mln
-3,55 mln
-5,42 mln
Other non operating income
-11,00K
22,00K
4,00K
-49,00K
EBT including unusual items
38,01 mln
2,39 mln
-4,28 mln
-3,41 mln
EBT excluding unusual items
47,82 mln
3,91 mln
-4,25 mln
-6,26 mln
Income tax expense
-
3,00K
28,00K
-
Effective tax rate
-
0,13%
-0,65%
-
Other operating expenses
-
-
-
-
Net income
38,01 mln
2,39 mln
-4,30 mln
-3,41 mln
Net profit margin
38,73%
13,58%
-124,62%
-213,54%
Earnings per share
3,50
0,19
-0,32
-0,35
Interest and investment income
236,00K
143,00K
204,00K
100,00K
Interest expense
-1,02 mln
-972,00K
-909,00K
-894,00K
Net interest expenses
-781,00K
-829,00K
-705,00K
-794,00K
Depreciation and amortization charges
-
-
-
-
EBITDA
50,41 mln
5,62 mln
-3,19 mln
-4,37 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer